Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
12.52 USD | -2.45% | -4.55% | +4.50% |
01/04 | Liquidia Says US FDA Cleared to Approve Yutrepia to Treat Hypertension | MT |
01/04 | Liquidia's Yutrepia Cleared for Potential FDA Approval Following Court Ruling | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+4.50% | 981M | |
+33.05% | 700B | |
-4.59% | 358B | |
+20.03% | 330B | |
+4.65% | 287B | |
+15.72% | 236B | |
+6.66% | 202B | |
-9.24% | 197B | |
+4.63% | 161B | |
-3.32% | 157B |
- Stock Market
- Equities
- LQDA Stock
- News Liquidia Corporation
- United Therapeutics Sues FDA Over Handling of Drug Application of Rival Liquidia